Technology
Theme
AI infrastructure remains the market’s dominant technology narrative, with demand broadening from GPUs into networking, optical connectivity, memory, storage, power management, EDA, and enterprise software. The market is rewarding measurable backlog, contracted revenue, and AI monetization—but punishing premium valuations when execution or margins disappoint.
Movers
- NVDA(Nvidia): Continued to anchor the AI complex through Dell’s accelerating AI server demand and a strategic $3.5 billion MediaTek investment. The move extends Nvidia’s ecosystem from data centers into edge, PC, and automotive AI.
- AMD(Advanced Micro Devices): Q2 revenue rose 50% year over year to $11.5 billion, with data-center revenue more than doubling. Saudi, European, Dell, and Broadcom-linked deployments strengthen AMD’s credibility as the leading open-ecosystem alternative to Nvidia.
- AVGO(Broadcom): AI semiconductor revenue reached $10.8 billion, up 143%, while VMware adds a high-margin enterprise software layer. Broadcom is increasingly a full-stack AI infrastructure platform rather than a pure chip supplier.
- DELL(Dell Technologies): AI server revenue reached $16.1 billion in Q1, up 757%, with a $51.3 billion backlog. The upcoming earnings report carries elevated risk after a 264% year-to-date rally and options-implied volatility near 11%.
- CSCO(Cisco Systems): Reported $4 billion of AI orders in Q4 and $9.3 billion for FY26. Its AMD-HUMAIN partnership positions Cisco as the networking backbone for sovereign AI deployments.
- MU(Micron Technology): HBM4 demand, 16 long-term customer agreements, and nearly $1 billion in HBM4 revenue commitments support a structural memory thesis. However, the stock’s 228% year-to-date gain and elevated insider selling raise the bar for further upside.
- MRVL(Marvell Technology): The $5.5 billion Celestial AI acquisition targets photonic fabric technology and reinforces Marvell’s custom-silicon and optical strategy. The 10.3% selloff after weak margin guidance shows that the market now demands earnings conversion, not just strategic positioning.
- LITE(Lumentum): Nvidia’s $2 billion investment and a planned U.S. photonics fab validate Lumentum’s role in 800G and 1.6T optical interconnects. Customer concentration and a 38x forward P/E remain material risks.
- CDNS(Cadence Design Systems): Q2 revenue grew 24.2%, free cash flow nearly doubled, and the €2.7 billion Hexagon Design & Engineering acquisition expands Cadence into structural analysis. The stock’s muted post-earnings response creates a contrarian setup around durable recurring revenue and AI-driven design complexity.
- SNPS(Synopsys): Projected annual free cash flow rose to $2.6 billion, $600 million above prior expectations. The decision to prioritize reinvestment over buybacks strengthens balance-sheet flexibility for AI-centric EDA expansion.
- SNDK(Sandisk): Revenue jumped 371% and operating margin reached 78%, but David Tepper’s complete exit after a 3,000% rally is a clear warning that cycle and valuation risk are overtaking fundamentals.
- GOOGL(Alphabet): Google Cloud revenue rose 82%, but roughly $200 billion of annual AI infrastructure spending is driving higher liabilities, interest expense, and suspended buybacks. Investors need proof of returns before rewarding further capex.
- MSFT(Microsoft): Nearly 40 million registered AI agents, an EY 400,000-seat E7 deployment, secured HBM capacity, and the financing of IREN’s GPU buildout reinforce Microsoft’s enterprise AI leadership. This remains the cleanest large-cap AI monetization story.
- CRM(Salesforce): Agentforce and Data 360 ARR reached nearly $3.9 billion, up 210%, while agentic work units rose 97% sequentially. Dreamforce must show that premium AI adoption is expanding beyond the current 5% of users.
- NOW(ServiceNow): AI ACV surpassed $1 billion and the AI Control Tower is live with more than 500 customers. This is one of the clearest examples of agentic AI converting into enterprise contract value.
- OKTA(Okta): AI-agent products represented 30% of bookings and lifted average contract value by 40%. Okta is becoming an identity layer for non-human agents, although Microsoft’s bundled security suite remains the principal competitive threat.
- CRWD(CrowdStrike): Falcon Flex ARR exceeded $2.29 billion and total ARR reached $5.84 billion. Integrations with Snowflake, Commvault, SailPoint, and Zscaler position CrowdStrike as the consolidation point for AI-native security.
- ZS(Zscaler): Z-Flex contract value rose 60% sequentially, but FY27 growth is expected to slow to roughly 16%. Its integration into CrowdStrike’s Project QuiltWorks reinforces CrowdStrike’s platform advantage at Zscaler’s strategic expense.
- SHOP(Shopify): B2B GMV grew 76%, billings rose 33.1%, and the company authorized a $3 billion buyback. The business is strengthening, but a 151x P/E leaves almost no execution margin.
- MDB(MongoDB): Revenue rose 25.2% and the company added 96 high-value enterprise clients. The 43.8% monthly rally has made the upcoming earnings report a high-risk catalyst.
- HPE(Hewlett Packard Enterprise): AI server demand is strong but constrained by supply-chain bottlenecks. Its earnings report will test whether AI demand is translating into shipments and stable margins.
- TYL(Tyler Technologies): A near-complete migration to AWS and 95% SaaS penetration in new contracts validate its cloud transition. The stock remains under-owned relative to the quality of its recurring public-sector revenue.
- PTC(PTC): Revenue declined 6.8%, yet the stock rose 18.2% after earnings. The gap between weak execution and market optimism is a short-side risk.
Actionable Ideas (Positive)
- NVDA(Nvidia): Use pullbacks to add exposure to the AI compute and ecosystem leader. The MediaTek investment broadens the addressable market beyond data centers.
- AVGO(Broadcom): Favor Broadcom over higher-multiple challengers where AI growth, 68%–69% EBITDA margins, and VMware integration provide a stronger risk-adjusted profile.
- MSFT(Microsoft): Maintain as a core AI holding. Agent adoption, enterprise distribution, and secured memory supply provide unusually visible monetization.
- CDNS(Cadence Design Systems): Buy weakness after the muted post-earnings reaction. The Hexagon acquisition and recurring revenue base support a durable EDA compounder thesis.
- CSCO(Cisco Systems): Accumulate for exposure to sovereign AI networking at a valuation materially below pure-play AI infrastructure names.
Actionable Ideas (Negative)
- SNDK(Sandisk): Reduce or hedge after the parabolic rally. Tepper’s exit and the memory-cycle sensitivity create downside asymmetry despite strong current margins.
- CRDO(Credo Technology): Avoid chasing the 62% year-to-date rally. Two customers provide 61%–81% of revenue without long-term contracts, creating a major earnings-gap risk.
- TEAM(Atlassian): Avoid on valuation. A quarterly loss and a 128% premium to RBC’s fair value leave the stock vulnerable if AI monetization slows.
- CIFR(Cipher Mining): Sell into strength. Only 700 MW of a 5.3 GW portfolio is contracted, while Q2 revenue fell to $25 million after mining operations were decommissioned.
- GOOGL(Alphabet): Underweight versus Microsoft until the company demonstrates that its massive AI capex is producing sufficient incremental earnings and cash flow.
Financials
Theme
Financials split sharply between high-quality compounders benefiting from rates, capital markets, and recurring fees and balance-sheet or payout stories exposed to credit, leverage, and margin compression. Alternative asset managers and payments networks remain strong, while weaker lenders and over-distributed vehicles are being repriced.
Movers
- JPM(JPMorgan Chase): Q2 revenue rose 27% to $58.02 billion, with 2026 NII guidance raised to $105.5 billion and a $50 billion buyback. Its housing commitment and market influence reinforce its position as the sector benchmark.
- BAC(Bank of America): NII rose 9% year over year and the dividend increased 14%, but a roughly 2% NIM and modest TBVPS growth reveal a reliance on loan volume rather than pricing power.
- PNC(PNC Financial): A 5.81% premarket gain, 21.2% dividend growth, and a 4.85 quantitative score make PNC one of the strongest regional-bank setups.
- ALL(Allstate): Eleven upward estimate revisions in 30 days and a 45.3% average EPS surprise support a high-conviction insurance compounder thesis.
- ACGL(Arch Capital), EG(Everest Group), and RNR(RenaissanceRe): Reinsurers are scaling third-party capital and ILS platforms as traditional pricing softens. RNR’s fee income nearly doubled to $177.2 million, while EG’s third-party capital reached $3.4 billion.
- AON(Aon): The $17 billion USI acquisition expands middle-market exposure and adds $395 million of projected synergies, but leverage is expected to reach 4.5x. The 7%–10% stock decline signals clear investor concern over M&A overreach.
- KKR(KKR): The USI sale generated a 6x return and $2 billion of adjusted net income, validating KKR’s long-duration operating model and strengthening the case for alternative asset managers with realizations.
- AMP(Ameriprise Financial): Tangible book value grew 19.1% annually over two years while valuation remains near 11x forward earnings. This is a rare combination of capital compounding and discount valuation.
- PYPL(PayPal): The 12.7% post-earnings selloff reflected 5% revenue growth, flat active accounts, and an 8% decline in operating income. The turnaround remains unproven.
- AFRM(Affirm): GMV grew 36% and cardholders more than doubled, but the $4.62 EPS beat was driven by a $1.45 billion tax benefit. The business is strong; the accounting quality and valuation are not.
- COIN(Coinbase): Tokenization and on-chain lending ambitions are strategically relevant, but stagnant user growth, earnings volatility, and a 2.18 quantitative score weaken the near-term setup.
- UBS(UBS): U.S. wealth-management expansion is gaining momentum, but the Swiss capital-requirement dispute remains a major valuation risk.
- TROW(T. Rowe Price): A $6.5 billion quarterly AUM outflow threatens the long-term earnings base despite the company’s debt-free balance sheet and 4.57% yield.
Actionable Ideas (Positive)
- JPM(JPMorgan Chase): Own as the sector anchor. Strong NII, capital returns, and balance-sheet scale justify a premium to weaker banks.
- ALL(Allstate): Buy for earnings momentum and conservative capital deployment. The combination of repeated beats and upward revisions provides genuine catalyst support.
- AMP(Ameriprise Financial): Accumulate as a value-oriented wealth-management compounder with strong tangible-book growth and buyback support.
- RNR(RenaissanceRe): Favor for fee-based alternative-capital growth, which reduces dependence on volatile underwriting margins.
Actionable Ideas (Negative)
- AON(Aon): Underweight following the USI transaction until leverage and synergy delivery are demonstrated. The market’s immediate reaction correctly identifies integration and balance-sheet risk.
- PYPL(PayPal): Short or avoid. Weak account growth and declining operating income show that the “smart wallet” narrative has not yet translated into operating momentum.
- TROW(T. Rowe Price): Avoid for growth portfolios. Persistent active-management outflows threaten both earnings and future dividend growth.
- OWL(Blue Owl Capital): Avoid yield-chasing. An 801% payout ratio and inconsistent profitability make the dividend structurally vulnerable.
Healthcare
Theme
Healthcare news is dominated by GLP-1 competition, oncology label expansion, precision diagnostics, and platform-driven medical devices. The strongest setups combine regulatory approval with immediate commercial traction; the weakest are companies facing patent cliffs, clinical setbacks, or reimbursement-driven margin pressure.
Movers
- LLY(Eli Lilly): Zepbound delivered 25.5% average weight loss versus CagriSema’s 23%, while Mounjaro sales reached $18.6 billion in the first half. Cardiovascular-risk approval further strengthens Lilly’s GLP-1 franchise.
- NVO(Novo Nordisk): CagriSema failed to demonstrate non-inferiority to Zepbound, while Ozempic U.S. volume declined. The DKK 15 billion buyback cannot offset a deteriorating competitive position.
- VRTX(Vertex Pharmaceuticals): The $10 billion Crinetics acquisition adds oral CAH candidate atumelnant and directly challenges Neurocrine’s new growth engine.
- NBIX(Neurocrine Biosciences): Crenessity generated $337 million in first-half sales and captured 15% of the U.S. CAH population, but Vertex now has the resources to attack the franchise.
- REGN(Regeneron): Libtayo’s adjuvant approval reduced recurrence or death risk by 68% in high-risk skin cancer. The label expansion provides a clear commercial catalyst.
- BMRN(BioMarin): A global settlement with Ascendis creates 20% U.S. and 18% international royalties on Yuviwel through 2030, converting litigation risk into recurring cash flow.
- PFE(Pfizer) and MRK(Merck): The Padcev-Keytruda bladder-cancer combination delivered a 35% mortality reduction and expands the commercial opportunity for both companies.
- MRNA(Moderna): Positive Phase 3 melanoma vaccine data with Keytruda drove a major re-rating. The oncology validation is powerful, although losses and high valuation remain.
- RHHBY(Roche): Columvi reimbursement in Singapore supports the bispecific platform, but discontinuation of BioNTech’s autogene cevumeran trial undermines the mRNA cancer-vaccine thesis.
- ABT(Abbott Laboratories): The whole-milk Similac 360 launch adds five HMOs to a ready-to-feed formula at competitive pricing, strengthening Abbott’s high-margin nutrition franchise.
- DXCM(DexCom): OTC Stelo expands CGM into consumer metabolic health and is the most important growth catalyst in the diabetes-device universe.
- MDT(Medtronic): Cardiovascular ablation sales rose 78% globally and 124% in the U.S., but tariffs and the Diabetes spin-off make the next earnings report pivotal.
- NTRA(Natera), VCYT(Veracyte), and GMED(Globus Medical): Diagnostics and medical devices continue to show strong earnings execution, with Natera reaching positive free cash flow and Veracyte averaging a 41.8% earnings surprise.
- CSL(CSL): The U.S. Medicaid most-favored-nation pricing agreement creates a direct margin risk in one of CSL’s largest markets.
Actionable Ideas (Positive)
- LLY(Eli Lilly): Maintain a core long. Clinical superiority, cardiovascular labeling, and $18.6 billion of first-half Mounjaro sales support continued share gains.
- REGN(Regeneron): Buy on weakness following the Libtayo label expansion. A 68% reduction in recurrence or death creates a strong adoption and reimbursement narrative.
- BMRN(BioMarin): Buy for royalty-driven earnings visibility. The settlement monetizes IP without requiring incremental commercialization investment.
- DXCM(DexCom): Accumulate for the OTC metabolic-health expansion. Stelo materially broadens the addressable market beyond insured diabetes patients.
- NTRA(Natera): Favor as a diagnostics growth name that has crossed into positive free cash flow.
Actionable Ideas (Negative)
- NVO(Novo Nordisk): Underweight or pair against Lilly. CagriSema’s efficacy gap and weakening Ozempic volumes signal a meaningful loss of GLP-1 leadership.
- GILD(Gilead Sciences): Avoid until revenue and margin erosion stabilize. Five-year revenue growth is only 2.7%, while EPS and operating margins are declining.
- BMY(Bristol-Myers Squibb): Underweight. Camzyos faces a credible future threat from Braveheart’s BHB-1893, while the broader portfolio shows limited growth.
- CSL(CSL): Reduce exposure ahead of further pricing-policy implementation. International benchmarking could structurally compress U.S. margins.
Industrials
Theme
Industrial leadership is concentrating around defense modernization, grid and data-center construction, electrification, automation, and specialty manufacturing. Backlog and contract visibility are driving re-ratings, while companies with execution gaps or excessive valuation are being sold despite favorable end markets.
Movers
- PWR(Quanta Services): Backlog reached a record $53.4 billion, up 49%, and 2026 EPS guidance rose to $16.95. Quanta is the clearest large-cap beneficiary of grid, power, and data-center buildout.
- CAT(Caterpillar): Power & Energy backlog jumped to $72 billion, with revenue up 29%. Generators and turbines are turning Caterpillar into a direct AI power-infrastructure beneficiary.
- LMT(Lockheed Martin): A $59 billion Pentagon contract to triple Patriot production, alongside THAAD frameworks, creates a multi-year missile-defense cycle.
- NOC(Northrop Grumman), GD(General Dynamics), and KTOS(Kratos Defense): Missile-defense and autonomous-aircraft programs are expanding the defense backlog. Northrop and Lockheed offer scale; Kratos offers higher growth but greater execution risk.
- HWM(Howmet Aerospace): SpaceX’s move toward in-house turbine blades erased more than $8 billion of market value. The threat may validate demand, but it directly challenges Howmet’s pricing power and 50%-plus market share.
- EME(EMCOR Group): Raised 2026 guidance to $20.0–$20.5 billion of revenue and $32.00–$33.25 of EPS, supported by record RPO. This is a direct read-through to AI data-center construction demand.
- FIX(Comfort Systems): Projected earnings growth of 58.8% and cash-flow growth of 74.3% place FIX among the strongest construction and mechanical-services beneficiaries.
- J(Jacobs Solutions): A $28.9 billion backlog provides stability, but Quanta’s $53.4 billion backlog and 52.3% projected EPS growth show that Jacobs is losing leadership in the current infrastructure cycle.
- HON(Honeywell): The Aerospace spin-off sharpens the portfolio around higher-margin businesses and offers a credible margin and capital-allocation reset.
- ROK(Rockwell Automation): AI-enabled Plex and FactoryTalk workflows strengthen the long-term thesis, but a 39.9x P/E and 18.3% DCF overvaluation leave limited margin for error.
- ZBRA(Zebra Technologies): AI-enabled mobile computers, RFID, and scanners are supported by productivity data showing potential logistics and retail gains of up to 21%.
- NUE(Nucor), STLD(Steel Dynamics), and CMC(Commercial Metals): Domestic steel and infrastructure names are benefiting from tariffs, reshoring, and strong cash generation. CMC’s EBITDA rose 77.3%, while STLD projects a further $650–$700 million uplift.
- BAH(Booz Allen Hamilton), IR(Ingersoll Rand), and OC(Owens Corning): Flat organic growth, weak ROIC, and declining EPS expose a group failing to convert favorable infrastructure demand into shareholder value.
Actionable Ideas (Positive)
- PWR(Quanta Services): Buy for the strongest backlog and earnings-growth combination in the infrastructure group.
- CAT(Caterpillar): Accumulate on pullbacks. The $72 billion Power & Energy backlog creates multi-year visibility tied directly to data-center power demand.
- LMT(Lockheed Martin): Own for defense-cycle exposure with unusually strong procurement visibility and strategic importance.
- EME(EMCOR Group): Buy for direct exposure to AI data-center construction and credible guidance upgrades.
- FIX(Comfort Systems): Favor as a higher-growth HVAC and electrical infrastructure play with exceptional cash-flow momentum.
Actionable Ideas (Negative)
- HWM(Howmet Aerospace): Underweight after the SpaceX disruption shock. Even if near-term displacement is limited, the announcement challenges the durability of Howmet’s moat at a 50x forward P/E.
- ROK(Rockwell Automation): Trim on valuation. AI adoption is attractive, but open-source alternatives and interoperability risk undermine the premium multiple.
- BAH(Booz Allen Hamilton): Avoid until revenue growth reaccelerates. Flat revenue and stagnant margins make it a weak substitute for faster-growing defense and AI infrastructure names.
- OC(Owens Corning): Avoid as a value trap. EPS has declined 20.2% annually despite construction-sector demand.
Transportation
Theme
Transportation is splitting between airlines and logistics operators with credible demand or pricing power and companies suffering from labor, freight, or execution pressure. International aviation and specialized logistics remain more attractive than low-margin domestic carriers.
Movers
- DAL(Delta Air Lines): Berkshire increased its stake 44%, signaling a regime change under Greg Abel and renewed institutional confidence in premium airlines.
- UAL(United Airlines): New A321XLR routes to Milan and Osaka, premium cabins, and Starlink connectivity strengthen the international growth thesis, although labor costs remain a margin constraint.
- AAL(American Airlines) and ALK(Alaska Air Group): Both face severe earnings deterioration, with EPS estimates cut 977.7% and 142.1%, respectively. Revenue growth is not translating into profitability.
- AER(AerCap): Four consecutive earnings beats, 23.3% projected 2026 earnings growth, and upward revisions make AerCap a standout in transportation equipment leasing.
- EXPD(Expeditors International): A 28.6% earnings-growth forecast and 17.15% average earnings surprise support a high-quality logistics setup.
- KNX(Knight-Swift): MD Sass’s contrarian endorsement reflects expectations for a trucking supply contraction and improved freight pricing.
- ZIM(ZIM Integrated Shipping): The Outperform upgrade reflects improving freight-market sentiment, but the cyclical shipping backdrop remains fragile.
- UPS(United Parcel Service): Leadership transition and the fading Amazon relationship leave investors waiting for proof that the company can build a profitable integrated-logistics model.
- UBER(Uber): More than 1,000 autonomous vehicles and robots from Avride and Serve Robotics are operating on Uber’s network, giving Uber a credible path toward driver-independent delivery economics.
Actionable Ideas (Positive)
- DAL(Delta Air Lines): Buy selectively. Berkshire’s position change is a powerful sentiment catalyst, while Delta’s premium network and loyalty economics offer better quality than most airline peers.
- AER(AerCap): Own for earnings visibility and disciplined capital allocation in an otherwise challenged transportation complex.
- EXPD(Expeditors International): Favor for reliable earnings execution and lower operational leverage than asset-heavy carriers.
- UBER(Uber): Accumulate for long-term autonomous delivery optionality. The platform, rather than vehicle ownership, is the strategic asset.
Actionable Ideas (Negative)
- AAL(American Airlines) and ALK(Alaska Air Group): Avoid or short into weak rallies. Extreme EPS estimate cuts point to structural margin and demand problems.
- UPS(United Parcel Service): Stay underweight until the leadership transition and post-Amazon growth strategy produce measurable margin improvement.
Consumer Discretionary
Theme
Consumer discretionary is rewarding brand strength, value positioning, and digital engagement, but high multiples and fragile consumer demand are producing sharp binary reactions. Retailers with real traffic and margin execution are outperforming acquisition-heavy or premium-valued peers.
Movers
- BBY(Best Buy): Comparable sales grew 4.1%, marketplace GMV reached $300 million, and AI tools are strengthening the digital ecosystem. Memory inflation is lifting prices while reducing unit volume.
- TJX(TJX Companies): A 4% comp increase and higher guidance reinforce the defensive value-retail thesis, despite an 11.8% year-to-date decline.
- URBN(Urban Outfitters): Revenue rose 8%, FP Group comps rose 10%, and gross margin expanded despite freight and tariff pressure. Identity-led brands are outperforming broad apparel retail.
- DKS(Dick’s Sporting Goods): The Foot Locker acquisition delivered 3.6% negative comps and forced an EPS-guidance cut. Integration risk has overtaken the original scale thesis.
- LULU(Lululemon): U.S. sales are projected to decline 10.5%, with EPS expected to fall 42.3%. International growth is not yet sufficient to offset the core-market slowdown.
- CHWY(Chewy): Attractive valuation and a pet-health expansion provide upside, but declining estimates and a 4.2% operating margin keep the setup event-driven.
- W(Wayfair): A 30% post-earnings surge reflects improved EBITDA, order trends, and AI personalization. The turnaround is gaining